DE59309756D1 - 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung - Google Patents

4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung

Info

Publication number
DE59309756D1
DE59309756D1 DE59309756T DE59309756T DE59309756D1 DE 59309756 D1 DE59309756 D1 DE 59309756D1 DE 59309756 T DE59309756 T DE 59309756T DE 59309756 T DE59309756 T DE 59309756T DE 59309756 D1 DE59309756 D1 DE 59309756D1
Authority
DE
Germany
Prior art keywords
iminoquinolines
preparation
image
formula
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59309756T
Other languages
German (de)
English (en)
Inventor
Uta-Maria Billhardt-Troughton
Manfred Roesner
Rudolf Bender
Christoph Meichsner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DE59309756T priority Critical patent/DE59309756D1/de
Application granted granted Critical
Publication of DE59309756D1 publication Critical patent/DE59309756D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DE59309756T 1992-06-27 1993-06-22 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung Expired - Lifetime DE59309756D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE59309756T DE59309756D1 (de) 1992-06-27 1993-06-22 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4221210 1992-06-27
DE59309756T DE59309756D1 (de) 1992-06-27 1993-06-22 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
DE59309756D1 true DE59309756D1 (de) 1999-10-07

Family

ID=6462017

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59309756T Expired - Lifetime DE59309756D1 (de) 1992-06-27 1993-06-22 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung

Country Status (19)

Country Link
US (1) US5602146A (pt-PT)
EP (1) EP0579968B1 (pt-PT)
JP (1) JP3605123B2 (pt-PT)
KR (1) KR940005577A (pt-PT)
CN (1) CN1083477A (pt-PT)
AT (1) ATE184003T1 (pt-PT)
AU (1) AU670435B2 (pt-PT)
CA (1) CA2099213C (pt-PT)
DE (1) DE59309756D1 (pt-PT)
DK (1) DK0579968T3 (pt-PT)
ES (1) ES2136628T3 (pt-PT)
GR (1) GR3031853T3 (pt-PT)
HU (1) HUT70040A (pt-PT)
IL (1) IL106147A (pt-PT)
MX (1) MX9303843A (pt-PT)
NZ (1) NZ247993A (pt-PT)
PH (1) PH31682A (pt-PT)
TW (1) TW304945B (pt-PT)
ZA (1) ZA934576B (pt-PT)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344452A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4428932A1 (de) * 1994-08-16 1996-02-22 Hoechst Ag Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19613591A1 (de) * 1996-04-04 1997-10-09 Hoechst Ag Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
WO2004035577A2 (en) * 2002-10-16 2004-04-29 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
WO2005117904A2 (en) * 2004-04-14 2005-12-15 Gilead Sciences, Inc. Phosphonate analogs of hiv integrase inhibitor compounds
KR20090104877A (ko) * 2007-01-23 2009-10-06 후지필름 가부시키가이샤 옥심 화합물, 감광성 조성물, 컬러 필터, 그 제조방법 및 액정표시소자
JP5305704B2 (ja) * 2008-03-24 2013-10-02 富士フイルム株式会社 新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
JP6483382B2 (ja) * 2014-09-16 2019-03-13 株式会社Adeka 感光性樹脂組成物、その硬化物
JP6734416B2 (ja) * 2019-02-13 2020-08-05 株式会社Adeka 新規化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US758568A (en) * 1903-05-29 1904-04-26 William E Snediker Wrench.
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents
AU6728687A (en) * 1985-11-21 1987-07-01 Anheuser-Busch Companies Inc. Glucose tolerance factor and method of making same
US4985439A (en) * 1985-11-21 1991-01-15 Anheuser-Busch Companies, Inc. Glucose tolerance factor and method of making same
US5192768A (en) 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
DK0509398T3 (da) * 1991-04-15 2002-01-14 Aventis Pharma Gmbh Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse

Also Published As

Publication number Publication date
DK0579968T3 (da) 2000-03-27
CA2099213C (en) 2005-11-29
ATE184003T1 (de) 1999-09-15
EP0579968B1 (de) 1999-09-01
GR3031853T3 (en) 2000-02-29
JPH0673012A (ja) 1994-03-15
MX9303843A (es) 1994-01-31
ES2136628T3 (es) 1999-12-01
CA2099213A1 (en) 1993-12-28
NZ247993A (en) 1995-11-27
JP3605123B2 (ja) 2004-12-22
EP0579968A1 (de) 1994-01-26
CN1083477A (zh) 1994-03-09
IL106147A (en) 1997-06-10
US5602146A (en) 1997-02-11
HU9301875D0 (en) 1993-09-28
IL106147A0 (en) 1993-10-20
PH31682A (en) 1999-01-18
TW304945B (pt-PT) 1997-05-11
AU4149293A (en) 1994-01-06
KR940005577A (ko) 1994-03-21
ZA934576B (en) 1994-01-31
AU670435B2 (en) 1996-07-18
HUT70040A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
DE59309902D1 (de) Azachinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE59209965D1 (de) Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE230732T1 (de) Imidazol-derivate mit biphenylsulfonylharnstoff- oder biphenylsulfonylurethan-seitenkette, verfahren zu ihrer herstellung und ihre verwendung
DE59309360D1 (de) Guanidinalkyl-1, 1-bisphosphonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE59105897D1 (de) Substituierte Azole, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung.
DE59209292D1 (de) Azol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE58907421D1 (de) Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE59309756D1 (de) 4-Iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
MY132057A (en) Quinoxalinones, a process for their preparation and their use
ATE66209T1 (de) Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
DE69118850D1 (de) Derivate der 1,4-Benzothiazin-2-essigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69112432D1 (de) Derivate von methylpiperazinoazepin, verfahren zu ihrer herstellung und verwendung.
DE3851979D1 (de) Substituierte Vinylcephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
DE3578866D1 (de) 2,3-diamino-2,3-didesoxyhexose-derivate, verfahren zu ihrer herstellung und ihre verwendung.
DE59001431D1 (de) 1-methoxypyrimidinyl-1h-1,2,4-triazol-3-sulfonsaeurenitroanilide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung.
ES2054631T3 (es) 1-(2-halogeno-alcoxi-bencenosulfonil)-3-heteroaril-ureas, 3-substituidas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH, 65929 FRANKFURT,

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,